Open Access. Powered by Scholars. Published by Universities.®

Education Commons

Open Access. Powered by Scholars. Published by Universities.®

Journal

PDF

Medicine and Health Sciences

Utah State University

2023

Outcomes and Impact Quarterly

Articles 1 - 2 of 2

Full-Text Articles in Education

Addressing The Opioid Crises: An Evaluation Of The Community Opioid Education Pilot Program, Gabriela Murza, Cris Meier, Lily Ward, Sydney O'Shay, Dru Faldmo Oct 2023

Addressing The Opioid Crises: An Evaluation Of The Community Opioid Education Pilot Program, Gabriela Murza, Cris Meier, Lily Ward, Sydney O'Shay, Dru Faldmo

Outcomes and Impact Quarterly

Utah's opioid crisis presents unique challenges as progress was hindered by the COVID-19 pandemic. This pilot study assessed the effectiveness of a brief webinar-based professional development program aimed at improving knowledge and confidence among health and behavioral healthcare professionals. Results indicated positive changes in participants' confidence and knowledge regarding opioid treatment options, misuse, and connecting individuals to resources.


Impact Of An Opioid Harm Reduction Consortium: Emergency And Justice Engagement, Maren Wright Wright Voss, Gabriele Ciciurkaite, Matthew Huntington, Melissa Flint, Emily Hamilton, Jennifer Peatross Oct 2023

Impact Of An Opioid Harm Reduction Consortium: Emergency And Justice Engagement, Maren Wright Wright Voss, Gabriele Ciciurkaite, Matthew Huntington, Melissa Flint, Emily Hamilton, Jennifer Peatross

Outcomes and Impact Quarterly

Utah State University Extension engaged first responders and law enforcement officials in a consortium to identify local needs related to opioid use disorder (OUD). To this end, the Tooele Opioid Response Network (TORN) conducted three first-responder harm reduction summits to meet local overdose prevention needs. The initiative trained over 200 personnel, which resulted in an 87.5% increase in knowledge related to harm reduction. TORN also facilitated the acquisition of $90,000 in funding for jail-based opioid medication and the disbursement of 400 naloxone kits and training to incarcerated persons at discharge.